These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Duchenne muscular dystrophy. Morphological study of erythrocytes after treatment with L-alpha-lysophosphatidyl-choline in dystrophic patients and in the carrier state. Dellantonio R, Capriotti M, Angeleri F, Curatola G, Mazzanti L, Bertoli E, Lenaz G. Acta Neurol Belg; 1981 Dec; 81(4):193-8. PubMed ID: 7293730 [Abstract] [Full Text] [Related]
11. Fluidity of erythrocyte membranes from patients with Duchenne muscular dystrophy: studies in intact erythrocytes and in ghosts. Capriotti M, Dellantonio R, Angeleri F, Curatola G, Mazzanti L, Leporoni B, Lenaz G. Boll Soc Ital Biol Sper; 1980 Jul 30; 56(14):1465-8. PubMed ID: 6255973 [Abstract] [Full Text] [Related]
12. Erythrocytes in Duchenne dystrophy: osmotic fragility and membrane deformability. Somer H, Chien S, Sung LA, Thurn A. Neurology; 1979 Apr 30; 29(4):519-22. PubMed ID: 571552 [Abstract] [Full Text] [Related]
13. Progressive muscular dystrophy type Duchenne. I. Spin label studies on the physico-chemical state of erythrocyte membranes. Dellantonio R, Capriotti M, Di Bella P, Angeleri F, Bertoli E, Curatola G, Lenaz G. Boll Soc Ital Biol Sper; 1979 Jun 30; 55(11):1021-7. PubMed ID: 232983 [Abstract] [Full Text] [Related]
14. Erythrocyte membrane abnormalities in Duchenne muscular dystrophy monitored by saturation transfer electron paramagnetic resonance spectroscopy. Wilkerson LS, Perkins RC, Roelofs R, Swift L, Dalton LR, Park JH. Proc Natl Acad Sci U S A; 1978 Feb 30; 75(2):838-41. PubMed ID: 204936 [Abstract] [Full Text] [Related]
15. Morphological variations of erythrocytes in Duchenne muscular dystrophy and in carrier state. Capriotti M, Dellantonio R, Angeleri F, Curatola G, Mazzanti L, Bertoli E, Lenaz G, Leporoni B. Boll Soc Ital Biol Sper; 1980 Jul 30; 56(14):1459-64. PubMed ID: 7448043 [No Abstract] [Full Text] [Related]
16. [Erythrocyte membrane in Duchenne muscular dystrophy. I. Sensitivity to lysolecithin in dystrophic patients and their families]. Grilli G, Bravi S, Angeleri F, Colombi A. Boll Soc Ital Biol Sper; 1980 Dec 15; 56(23):2399-402. PubMed ID: 7470282 [Abstract] [Full Text] [Related]
17. Reduced deformability of erythrocyte membranes from patients with Duchenne muscular dystrophy. Percy AK, Miller ME. Nature; 1975 Nov 13; 258(5531):147-8. PubMed ID: 1186894 [No Abstract] [Full Text] [Related]
18. [Erythrocyte membrane in Duchenne muscular dystrophy. II. Fluidity of lipids in dystrophic patients and their families]. Zolese G, Campagnoli P, Colombi A, Mazzanti L. Boll Soc Ital Biol Sper; 1980 Dec 15; 56(23):2403-7. PubMed ID: 6258613 [Abstract] [Full Text] [Related]
19. Detection of carriers of human Duchenne muscular dystrophy by freeze-fracture analysis of erythrocyte plasmalemmal intramembrane particles. Shivers RR, Martin K, Atkinson BG. Am J Clin Pathol; 1986 Feb 15; 85(2):131-4. PubMed ID: 3946298 [Abstract] [Full Text] [Related]
20. Lipids and proteins of erythrocyte membrane in Duchenne muscular dystrophy. Kobayashi T, Mawatari S, Kuroiwa Y. Clin Chim Acta; 1978 May 02; 85(3):259-66. PubMed ID: 657522 [Abstract] [Full Text] [Related] Page: [Next] [New Search]